| |
|
|
|
|
|
|
|||
|
CORRESPONDENCE We read with great interest the article by Yagi et
al1 on the expression of nonfunctional Ikaros isoform 6 (Ik6) in childhood acute myeloid leukemia (AML). The authors reported
that Ik6 was expressed in 7 of 10 cases of M4 and M5 AML
(French-American-British [FAB] classification), but in none with M2
and M7 AML. Their M4 and M5 cases with Ik6 expression had karyotype
abnormalities: inv(16), inv(6), inv(9), del(11), +6, +8, +18, +21, or
t(9;11). We also determined whether Ik6 was expressed in samples from
24 Japanese adults with AML using reverse transcriptase-polymerase chain reaction2; 7 cases of M1, 5 of M2, 2 of M3,
5 with cessation of M4, and 5 with cessation of M5. As shown in Table
1, all AML samples expressed Ik1 and/or Ik2 but not Ik6. Abnormal
karyotypes inv(16) (cases 17 and 18) and +8 (case 15) were also found
in adult AML M4 cases; however, expression of Ik6 was not detected in
these cases of AML. These findings indicate that Ik6 is expressed in
childhood AML but not in adult AML, and that expression of Ik6 in AML
is apparently not associated with karyotypes. Several reports
demonstrated that Ik6 is frequently expressed in B-precursor acute
lymphoblastic leukemia (pre-B ALL) in infants, young
children,3-6 and adults, and in childhood pre-T
ALL.7 We reported that Ik6 was detected in 16 of 36 patients with adult pre-B ALL but not in adult pre-T
ALL.2
Although the role of nonfunctional Ikaros isoforms in leukemogenic mechanisms is not fully understood, it should be kept in mind that the expression manner of IK-6 differs in adult, childhood, and infant acute leukemias.
Kazuhiro Nishii, Naoyuki Katayama, and Hiroshi Shiku Supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology from the Ministry of Health, Labour, and Welfare, Tokyo, Japan. References
1.
Yagi T, Hibi S, Takanashi M, et al.
High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis.
Blood.
2002;99:1350-1355 2. Nishii K, Katayama N, Miwa H, et al. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia. Leukemia. 2002;16:1285-1292[CrossRef][Medline] [Order article via Infotrieve].
3.
Sun L, Heerema N, Crotty L, et al.
Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
Proc Natl Acad Sci USA.
1999;96:680-685
4.
Sun L, Goodman PA, Wood CM, et al.
Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia.
J Clin Oncol.
1999;17:3753-3766
5.
Nakase K, Ishimaru F, Avitahl N, et al.
Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia.
Cancer Res.
2000;60:4062-4065 6. Olivero S, Maroc C, Beillard E, et al. Detection of different Ikaros isoforms in human leukaemias using real-time quantitative polymerase chain reaction. Br J Haematol 2000;110:826-830[CrossRef][Medline] [Order article via Infotrieve]. 7. Sun L, Crotty M-L, Sensel M, et al. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res. 1999;7:2112-2120. Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||